SYNBIOFF Trademark

Trademark Overview


On Tuesday, March 1, 2022, a trademark application was filed for SYNBIOFF with the United States Patent and Trademark Office. The USPTO has given the SYNBIOFF trademark a serial number of 79338517. The federal status of this trademark filing is REGISTERED as of Tuesday, November 21, 2023. This trademark is owned by SYNBALANCE SRL. The SYNBIOFF trademark is filed in the Chemical Products and Pharmaceutical Products categories with the following description:

Probiotic bacterial formulations for medical use; probiotic supplements; pharmaceutical and medicinal preparations for use in the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; pharmaceutical and medicinal preparations for use in the treatment of gastro-intestinal, immunity and uro-genital disorders, hyperlipidemia, sunburn, infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders, damaged skin and tissue, eye diseases and conditions, skin disorders, diabetes, erectile dysfunction, bone diseases, immune system related diseases and disorders, allergies, hypertension, epidermis, respiratory diseases, cardiovascular disorders, viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastroint...

Probiotic bacteria for use in the manufacture of pharmaceuticals and nutraceuticals
synbioff

General Information


Serial Number79338517
Word MarkSYNBIOFF
Filing DateTuesday, March 1, 2022
Status700 - REGISTERED
Status DateTuesday, November 21, 2023
Registration Number7220430
Registration DateTuesday, November 21, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 5, 2023

Trademark Statements


Goods and ServicesProbiotic bacterial formulations for medical use; probiotic supplements; pharmaceutical and medicinal preparations for use in the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; pharmaceutical and medicinal preparations for use in the treatment of gastro-intestinal, immunity and uro-genital disorders, hyperlipidemia, sunburn, infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders, damaged skin and tissue, eye diseases and conditions, skin disorders, diabetes, erectile dysfunction, bone diseases, immune system related diseases and disorders, allergies, hypertension, epidermis, respiratory diseases, cardiovascular disorders, viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders, respiratory diseases, asthma, allergic rhinitis, viral infections, gastro-intestinal diseases, halitosis, viral diseases, autoimmune diseases; pharmaceutical preparations for skin care; pharmaceutical preparations for use in urology; pharmaceutical preparations for the prevention of gastro-intestinal and urogenital infections, seasonal illness, common colds, cardiovascular disease, gastro-intestinal or local dysbiosis, allergies; pharmaceutical preparations for wounds; pharmaceutical preparations for animal skincare; pharmaceutical preparations acting on the central nervous system; dermatological pharmaceutical products; pharmaceutical skin lotions; pharmaceutical products for skin care for animals; anti-diabetic pharmaceuticals; ferments for pharmaceutical purposes; pharmaceutical agents affecting metabolism; ferments for pharmaceutical purposes, namely, for gastro-intestinal, immunity and uro-genital disorders; digestives for pharmaceutical purposes; pharmaceutical preparation for skin care; pharmaceuticals, namely, lipid lowering agents; milk ferments for pharmaceutical purposes
Goods and ServicesProbiotic bacteria for use in the manufacture of pharmaceuticals and nutraceuticals

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateFriday, April 22, 2022
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes052, 051, 005, 018, 006, 044, 046
Class Status Code6 - Active
Class Status DateFriday, April 22, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSYNBALANCE SRL
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressIT

Party NameSYNBALANCE SRL
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressIT

Party NameSYNBALANCE SRL
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressIT

Trademark Events


Event DateEvent Description
Monday, March 18, 2024FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, February 22, 2024FINAL DISPOSITION NOTICE SENT TO IB
Thursday, February 22, 2024FINAL DISPOSITION PROCESSED
Wednesday, February 21, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, November 21, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, November 21, 2023REGISTERED-PRINCIPAL REGISTER
Monday, October 16, 2023NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, September 27, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, September 27, 2023NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Tuesday, September 5, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 5, 2023PUBLISHED FOR OPPOSITION
Monday, September 4, 2023NOTIFICATION PROCESSED BY IB
Wednesday, August 16, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, August 16, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, August 16, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, July 28, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, July 27, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 26, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, July 26, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, May 27, 2023NEW REPRESENTATIVE AT IB RECEIVED
Sunday, May 14, 2023NEW REPRESENTATIVE AT IB RECEIVED
Wednesday, March 15, 2023REFUSAL PROCESSED BY IB
Wednesday, February 22, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, February 22, 2023REFUSAL PROCESSED BY MPU
Tuesday, December 27, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, December 26, 2022NON-FINAL ACTION WRITTEN
Tuesday, December 13, 2022ASSIGNED TO EXAMINER
Tuesday, April 26, 2022APPLICATION FILING RECEIPT MAILED
Friday, April 22, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, April 21, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB